Status:
ACTIVE_NOT_RECRUITING
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborating Sponsors:
Kaiser Permanente
University of California, Davis
Conditions:
HIV Infections
Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care servic...
Detailed Description
Tobacco use remains the leading preventable cause of death and illness in our society, and smoking rates are disproportionately high among people living with HIV. NCI, nicotine dependence researchers,...
Eligibility Criteria
Inclusion
- In care in the VA
- HIV+ serostatus
- Currently smoking 5+ cigarettes daily
- Access to cell phone with text messaging capabilities
- English speaking
Exclusion
- Psychosis, dementia or significant cognitive impairment documented in the EHR
- Documented or observed hearing or comprehension difficulties that would preclude participation in study telephone calls
- Currently receiving cessation counseling or using an FDA approved treatment to quit smoking
- Institutionalized/imprisoned
- Pregnant
Key Trial Info
Start Date :
June 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT04505371
Start Date
June 4 2021
End Date
February 28 2026
Last Update
October 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Puget Sound Health Care System Seattle Division
Seattle, Washington, United States, 98108